Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,795 articles
Neuroscientist Tommy Wood joins Mike Lustgarten to break down the science of brain health, cognitive resilience, and longevity strategies.
Mike Lustgarten explores whether the Bortz biological age clock beats PhenoAge as a tool for measuring how fast you're aging.
Dr. Douglas Vaughan explains how the protein PAI-1 drives aging and how targeting it could extend healthy human lifespan.
Mike Lustgarten and Dr. Dan Winer explore how gut health directly influences aging, disease risk, and longevity strategies.
Biotech startup NewLimit is screening transcription factors to reverse cellular aging via partial reprogramming and mRNA delivery.
Bioinformatician David Meyer explains how stochastic DNA changes power aging clocks and what that means for rejuvenation.
A UCSF researcher reveals that data access and reproducibility failures may be longevity science's biggest hidden bottleneck.
A Brazilian lab attempts to reproduce headline-making pig plasma rejuvenation results in rats — here's what they found.
Retro Biosciences used GPT-4b micro to engineer proteins that reverse cellular aging far more powerfully than evolution ever managed.
Public trust may be the missing ingredient for longevity advances. New cultural mapping reveals who believes — and who doesn't.
From CAR T-cell senolytics to AI-designed reprogramming factors, 2025 delivered landmark advances in aging science.
A new minimal model from physicists suggests aging is governed by just 3 variables — and most anti-aging drugs only address the first level.
